• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    3D Cell Culture Companies

    ID: MRFR/HC/4472-CR
    200 Pages
    Rahul Gotadki
    July 2025

    3D cell culture companies are at the forefront of developing technologies and products that enable researchers to grow and study cells in three-dimensional environments, more closely mimicking the conditions found in the human body. These companies provide innovative solutions for drug discovery, toxicology testing, disease modeling, and regenerative medicine.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    3D Cell Culture Market Research Report – Forecast to 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the 3D Cell Culture Market


    3D Cell Culture Key Companies*Disclaimer: List of key companies in no particular orderLatest 3D cell culture Companies Update


    • April 2023: The goal of ZEISS Ventures' investment in InSphero, a company in the health sciences, is to speed up the widespread use of 3D microtissues in scientific study and pharmaceutical development. Pharmaceutical industry innovator InSphero AG, which uses 3D spheroid and cell-based tests for drug development and safety assessment, has raised eight figures. It plans to put the money on marketing and scaling up its cryopreservation technology. Internal and foreign investors, including ZEISS Ventures, are taking part in this funding round. Phenotypic models of the smallest functional unit of a tissue or organ, 3D microtissues form the basis of InSphero's comprehensive solutions for preclinical medication safety and effectiveness testing. Scalable 3D technology, ISO-quality regulated 3D human tissue models, 3D-optimized medium, and specialized assay services and support are all part of these drug-discovery and testing systems.




    • June 2023: Two new collagen fiber products, CollaFibR and CollaFibR 3D scaffold, were just introduced by ioFibR, a pioneer in the field of tissue engineering. Collagen fibers made with 3D BioFibR's new and proprietary dry-spinning technology are now available for sale to the scientific and medical communities, and they offer significant advantages for tissue engineering and tissue culture applications. CollaFibR is a bioink additive used in the 3D printing of laboratory-scale tissue and organ models. CollaFibR functions as a biological rebar in bioinks that are used to print live tissues, mimicking the body's native cellular framework. With CollaFibR in the bioinks, various cell types may be built layer by layer to create highly functioning tissue and organ models with increased mechanical endurance.


    List of 3D cell culture Key companies in the market


    • PerkinElmer Inc. (the U.S.)




    • General Electric Company (U.S.)




    • Danaher (U.S.)




    • Thermo Fisher Scientific (U.S.)




    • Agilent Technologies Inc. (U.S.)




    • Qiagen (Germany)




    • Shimadzu Corporation (Japan)




    • Becton Dickinson and Company (U.S.)